| Return
to Health and Welfare section
DCM
"Cardio" RESEARCH
***NOTE THIS TAMU STUDY ONLY REQUIRES A NON-INVASIVE
SAMPLE (only blood or buccal (cheek swab) samples
required). WORLD-WIDE PARTICIPATION of Great Dane owners
and breeders IS ENCOURAGED! **** CONTACT DR. CLARK:
lclark@cvm.tamu.edu
Texas A&M University (TAMU) is currently
conducting research into dilated cardiomyopathy (DCM) in
the Great Dane:
CHF ACTIVE GRANT # 789:
Identification of Candidate Genes Causative for Dilated
Cardiomyopathy in the Dog
Abstract:
Dilated Cardiomyopathy causes severe heart disease and
death in the Great Dane, Boxer, and Doberman Pinscher,
among other breeds. The heart becomes enlarged and unable
to pump blood through the body, resulting in heart
failure. Identification of the gene or genes that cause
canine DCM will allow for early identification of affected
and carrier dogs and improve breeding programs by
eliminating these individuals from the breeding
population. We will utilize current genetic tools such as
linkage and microarray to help identify genes that cause
or contribute to DCM in the dog.
This is a
"two-pronged" approach with a clinical and genetic aspect.
ALL THAT IS REQUIRED is a DNA sample and the dog's
records. NO travel and no invasive procedures are
necessary. Worldwide participation is encouraged. Dilated
Cardiomyopathy (DCM) is a disease of the heart that causes
the cardiac muscle to become enlarged, weakened, and
unable to efficiently pump blood throughout the body.
There are many breeds of the domestic dog that have a high
prevalence of DCM, among them the Great Dane, Boxer, and
Doberman Pinscher. Studies of this disease have to date
been unsuccessful in definitively determining the gene or
genes causative for DCM. Our study includes (1) complex
segregation analysis to determine the mode of inheritance
of DCM in Great Danes, (2) linkage analysis to identify
chromosomal regions that may harbor genes responsible for
DCM, and (3) microarray technology to identify candidate
genes for DCM in Great Danes. Discovering the gene or
genes responsible for causing DCM in the Great Dane could
ultimately lead to a genetic test to help identify dogs
that are predisposed to DCM, providing breeders with the
ability to implement more judicious breeding programs.
Because DCM affects the human and has a similar clinical
presentation to the dog, identifying the gene or genes
causing DCM could present opportunities for new diagnostic
and treatment methods in humans.
For more
information, please contact the following:
Leigh Anne Clark, Ph.D. Canine Genetics Lab:
Email:
lclark@cvm.tamu.edu
Lab
phone: 979-845-5634
FAX:
979-845-9231
TAMU-College of Vet. Med.
Dept. of Pathobiology (MS4467)
Canine Genetics Lab: Attn: LCLARK
Rm 215, VMS Bldg.
College Station, TX
77845-4467
GDCA POC: JP Yousha
Chmn., Health & Welfare, GDCA
www.gdca.org/healthandwelfare.htm
danehealth@gdca.org
432-584-8940
OTHER CHF HEART RESEARCH RECENTLY SPONSORED BY THE GDCA
(VIA THE DAF FUND):
Widescale Genome Profiling in Great Danes with Dilated
Cardiomyopathy (DCM):
Summary of Research: Previous
studies involving widescale genome profiling in dogs with
heart disease has provided large amounts of data regarding
the pathophysiology and potential etiology of disease. We
propose to perform oligonucleotide microarray analysis of
over 25,000 genes in Great Danes with advanced dilated
cardiomyopathy. Microarray studies evaluate of a large
proportion of the total canine genome and produce a
molecular portrait of the disease process. The proposed
study will reveal the transcriptional activity of genes
suspected to be involved in the development of DCM, as
well as identify new candidate genes that merit further
study.
We need
Great Danes diagnosed with DCM and veteran Great Danes
without DCM to participate in a study currently being
conducted at the University of Pennsylvania. Dogs enrolled
will have to be willing to travel to the clinic in
question. For more information contact:
Mark A. Oyama, DVM, DACVIM-Cardiology
Department of Clinical Studies, School of Veterinary
Medicine
University of Pennsylvania, Philadelphia, PA 19104
215-898-2964 (office)
215-573-6232 (fax)
maoyama@vet.upenn.edu
Active Grant
No: 900-A:
Immunological Treatment of
Canine Dilated Cardiomyopathy Using a T-Lymphocyte
Modulator
Imulan Bio Therapeutics, LLC (Craig
Woods, BS, DVM, MS, MBA) Abstract:
Dilated cardiomyopathy (DCM) is one of several life
limiting heart diseases in dogs. Suspected causes
relate to nutrition, environment, infection, genetics,
and toxic exposure. Recently, research has strongly
implicated the immune system as a contributing factor
in DCM and congestive heart failure (CHF). A new
strategy has been developed using an immune system
modulator. This technology has demonstrated the
ability to restore cardiac function in lab animal
models of dilated cardiomyopathy. This study is
intended to determine if the same effects apply to
dogs with cardiomyopathy. If successful, this new
treatment could greatly contribute to managing this
disease process.
Permission to
reprint as submitted for educational purposes is given.
Updated by JP Yousha, Chair, H&R Committee, GDCA 2008.
Return
to Health and Welfare section
|